Overview
Pulmonary atresia with intact ventricular septum (PA-IVS) is a rare congenital heart defect present at birth in which the pulmonary valve fails to form properly, resulting in complete obstruction of blood flow from the right ventricle to the pulmonary artery. Unlike pulmonary atresia with a ventricular septal defect, the ventricular septum remains intact, meaning there is no hole between the two lower chambers of the heart. This condition critically impairs the heart's ability to send blood to the lungs for oxygenation. Survival after birth depends on the persistence of fetal circulatory pathways, particularly the patent ductus arteriosus (PDA), which allows some blood to reach the lungs. Without intervention, closure of the PDA leads to severe cyanosis (bluish discoloration of the skin due to low oxygen levels) and is life-threatening. The right ventricle in PA-IVS is often underdeveloped (hypoplastic), though its size can vary considerably among affected individuals. In some cases, abnormal connections between the right ventricle and the coronary arteries (sinusoidal communications or coronary fistulae) develop, which can make the coronary circulation dependent on the right ventricle — a feature known as right ventricle-dependent coronary circulation (RVDCC). This is a critical consideration in treatment planning because decompressing the right ventricle in such cases could compromise coronary blood flow and lead to myocardial ischemia. Other associated findings may include tricuspid valve abnormalities, right atrial enlargement, and an atrial septal defect or patent foramen ovale that allows right-to-left shunting. Immediate treatment after birth typically involves administration of prostaglandin E1 to maintain ductal patency, followed by surgical or catheter-based interventions. Treatment strategies depend on the anatomy and include radiofrequency perforation or surgical valvotomy of the pulmonary valve, creation of a systemic-to-pulmonary artery shunt (such as a modified Blalock-Taussig shunt), or staged single-ventricle palliation culminating in a Fontan procedure for patients with severely hypoplastic right ventricles. Some patients with adequate right ventricular size may ultimately achieve a biventricular repair. Long-term outcomes have improved significantly with advances in neonatal cardiac surgery and interventional cardiology, though lifelong cardiac follow-up is required.
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Pulmonary atresia-intact ventricular septum syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pulmonary atresia-intact ventricular septum syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Pulmonary atresia-intact ventricular septum syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pulmonary atresia-intact ventricular septum syndrome.
Community
No community posts yet. Be the first to share your experience with Pulmonary atresia-intact ventricular septum syndrome.
Start the conversation →Latest news about Pulmonary atresia-intact ventricular septum syndrome
No recent news articles for Pulmonary atresia-intact ventricular septum syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pulmonary atresia-intact ventricular septum syndrome
What is Pulmonary atresia-intact ventricular septum syndrome?
Pulmonary atresia with intact ventricular septum (PA-IVS) is a rare congenital heart defect present at birth in which the pulmonary valve fails to form properly, resulting in complete obstruction of blood flow from the right ventricle to the pulmonary artery. Unlike pulmonary atresia with a ventricular septal defect, the ventricular septum remains intact, meaning there is no hole between the two lower chambers of the heart. This condition critically impairs the heart's ability to send blood to the lungs for oxygenation. Survival after birth depends on the persistence of fetal circulatory pathw
How is Pulmonary atresia-intact ventricular septum syndrome inherited?
Pulmonary atresia-intact ventricular septum syndrome follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pulmonary atresia-intact ventricular septum syndrome typically begin?
Typical onset of Pulmonary atresia-intact ventricular septum syndrome is neonatal. Age of onset can vary across affected individuals.